Archive | Uncategorized

Viela Bio Spins Out of MedImmune

vielabio-logo-blue

Viela Bio Spins Out of MedImmune; Launches with Up to $250 Million Series A Financing from Investor Consortium Led by Boyu Capital, 6 Dimensions Capital, and Hillhouse Capital Viela Bio team will focus on developing medicines for severe autoimmune diseases by targeting critical pathways that are the root cause of disease Gaithersburg, MD, February 28, 2018 – Viela Bio […]

Technical.ly Baltimore: Where Steve Case sees opportunity for Baltimore’s startup community

AnchorVentures-LinkedIn-ProfilePhoto

At this point, Steve Case has seen many startup communities, as his Rise of the Rest bus tour has been to 33 cities. Speaking Thursday at Johns Hopkins’ FastForward 1812 in East Baltimore on Thursday night, the AOL cofounder said each community has a unique story and opportunity for growth. As far as the prospects for Baltimore, he pointed to increasing work […]

Comments Off on Technical.ly Baltimore: Where Steve Case sees opportunity for Baltimore’s startup community Continue Reading →

UMB’s New Ventures Initiative Fosters Commercialization

umventures-logo-trans

Innovative science at the University of Maryland, Baltimore is getting an extra boost through an innovative program fueled by UM Ventures called the “New Ventures Initiative” (NVI), which is headquartered in the Lion Brothers Building.   UMB’s New Ventures Initiative is designed to bring together management expertise, business formation strategy, a physical space, and early-stage capital […]

Comments Off on UMB’s New Ventures Initiative Fosters Commercialization Continue Reading →

My Guest Post on BioBuzz: An Interview with Analytical Informatics, Inc. CEO Chris Meenan – Part One

In part one of this two-part series, I talked with Maryland health IT executive Chris Meenan about his company Analytical Informatics, Inc. (AI), and what it takes to be a successful entrepreneur. This is part of a broader interview series. Chief executive: Chris Meenan, Co-founder and CEO, Analytical Informatics, Inc. (AI) Location: Baltimore, MD Started […]

Comments Off on My Guest Post on BioBuzz: An Interview with Analytical Informatics, Inc. CEO Chris Meenan – Part One Continue Reading →

BHI’s Rich Bendis Contributed to Special Report from White House Lab-to-Market Inter-Agency Summit

Bendis-242wide

BHI CEO Rich Bendis recently served as an expert panelist contributing to a special report from the “White House Lab-to-Market Inter-Agency Summit.” Panelists examined the U.S. federal government’s investment in drug R&D and the resulting private sector commercialization. According to the Summit report: Federal research has done exceedingly well at accomplishing its original intent, which […]

Comments Off on BHI’s Rich Bendis Contributed to Special Report from White House Lab-to-Market Inter-Agency Summit Continue Reading →

Rachel King of GlycoMimetics Named to 2013 PharmaVOICE 100

On August 1, 2013, PharmaVOICE included Rachel King, CEO of GlycoMimetics, among the 2013 PharmaVOICE 100 list. Established nine years ago by PharmaVOICE magazine, the PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life-sciences industry. These individuals illustrate what it means to think bigger, do more, and lead […]

Comments Off on Rachel King of GlycoMimetics Named to 2013 PharmaVOICE 100 Continue Reading →